Drug Profile
Carbamazepine intravenous - Lundbeck
Alternative Names: Carbamazepine IV; Carbella™; CarnexivLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator OVATION Pharmaceuticals
- Developer Ligand Pharmaceuticals; Lundbeck Inc
- Class Antidepressants; Antiepileptic drugs; Antimanics; Dibenzazepines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Epilepsy
Most Recent Events
- 22 Apr 2017 Pharmacodynamics and pharmacokinetics data from a phase I safety trial in Epilepsy presented at the 69th Annual Meeting of the American Academy of Neurology (AAN-2017)
- 07 Oct 2016 Registered for Epilepsy in USA (IV)
- 22 Apr 2016 US FDA accepts resubmission of NDA for carbamazepine intravenous for Epilepsy for review